Ying Jiang - Scotch Plains NJ, US Fang Liang Zhang - Fanwood NJ, US Nicholas J. Murgolo - Millington NJ, US Lin Luo - Edison NJ, US Jason S. Simon - Westfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 33/566
US Classification:
435 721, 435 72, 436501
Abstract:
The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.
Ying Jiang - Scotch Plains NJ, US Fang Liang Zhang - Fanwood NJ, US Nicholas J. Murgolo - Millington NJ, US Lin Luo - Edison NJ, US Jason S. Simon - Westfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 33/566 C07K 14/705
US Classification:
435 721, 435 71, 435 72, 436501
Abstract:
The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.
Antibodies And Functional Fragments Thereof That Specifically Bind An Rf-Amide Peptide Or A Precursor Thereof
Ying Jiang - Scotch Plains NJ, US Fang Liang Zhang - Fanwood NJ, US Nicholas J. Murgolo - Millington NJ, US Lin Luo - Edison NJ, US Jason S. Simon - Westfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07K 16/00 C12P 21/08
US Classification:
5303879, 5303881, 53038815, 4241391
Abstract:
The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.